CI Stock Analysis: Buy, Sell, or Hold?
CI - The Cigna Group
$274.11
2.84 (1.05%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026
4d
Get Alerted When CI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$327.65
Based on 3.4% avg growth
INTRINSIC VALUE TODAY
$203.44
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CI is currently trading at $274.11, which is considered slightly low relative to its 30-day fair value range of $272.31 to $280.40. The stock's valuation (Forward PE: 8.9) is in line with its historical norms (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This pessimistic expectation contrasts with the company's recent 165.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CI is in a downtrend. The price is approaching resistance at $281.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $326.92 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CI is in a downtrend. The price is approaching resistance at $281.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $326.92 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$272.31 -
$280.40
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.5% below Wall St target ($326.92)
Fair Price Analysis
30-Day Fair Range
$272.31 -
$280.40
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$265.75
Resistance Level
$281.49
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
8.90
Wall Street Target
$326.92
(+20.5%)
Revenue Growth (YoY)
9.5%
Earnings Growth (YoY)
165.4%
Profit Margin
2.3%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
8.9 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$269.64
(-1%)
2-Year Target
$268.02
(-1%)
3-Year Target
$266.42
(-2%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
$272.26
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 2.8%)
$737.75
(+172%)
Base:
(SPY PE: 8.9, Growth: 2.8%)
$294.60
(+9%)
Bear:
(PE: 7.6, Growth: 2.8%)
$250.41
(-8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 12.06 | Current EPS (TTM): $22.58
Bull Case
$404.22
(+48%)
Analyst growth 34.9%, PE expands to 13.3
Base Case
$367.48
(+34%)
Market implied 34.9%, PE stable at 12.1
Bear Case
$185.22
(-32%)
Severe decline -20.0%, PE contracts to 10.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.9 to 9.1
Stabilization Target:
$277.22
(+2.2%)
PE Expansion Potential:
+2.2%
Last updated: January 31, 2026 1:46 AM ET
Data refreshes hourly during market hours. Next update: 2:46 AM
Data refreshes hourly during market hours. Next update: 2:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian C Evanko
SELL
5368 shares
2025-10-03
Ro Khanna
SELL
2025-09-29
Julie Johnson
SELL
2025-09-25
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$95 | 61 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$395 | 53 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$44 | 53 HOLD |
Advanced CI Option Strategies
Professional options setups generated by AI based on today's CI price and gamma walls.
